Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?
10:56am, Wednesday, 04'th Dec 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 27.8% in Haemonetics (HAE). While the effectiveness of this highly sought-after metric is questionable, the pos
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?
10:51am, Wednesday, 04'th Dec 2024
Haemonetics inks a new agreement to sell its whole blood assets to GVS. The transaction is expected to be closed in the first quarter of 2025.
4 Medical Product Stocks to Buy From a Prospective Industry
10:45am, Wednesday, 04'th Dec 2024
An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable fac
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
01:16am, Tuesday, 03'rd Dec 2024
BOSTON , Dec. 3, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, tod
HAE or BSX: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 15'th Nov 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two companies is the best option for
Here's Why Haemonetics (HAE) is a Strong Value Stock
10:45am, Tuesday, 12'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet
11:00am, Monday, 11'th Nov 2024
The mean of analysts' price targets for Haemonetics (HAE) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand
09:01am, Monday, 11'th Nov 2024
HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics
10:35am, Thursday, 07'th Nov 2024
The headline numbers for Haemonetics (HAE) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street e
Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates
08:26am, Thursday, 07'th Nov 2024
Haemonetics (HAE) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.99 per share a year ago.
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
06:00am, Thursday, 07'th Nov 2024
Financial release accessible online BOSTON , Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended Sept
Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Wednesday, 06'th Nov 2024
Beyond analysts' top -and-bottom-line estimates for Haemonetics (HAE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quar
Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
09:44am, Monday, 04'th Nov 2024
Donidalorsen will be a first-in-class RNA-targeted medicine for hereditary angioedema, assuming approval Donidalorsen PDUFA date set for August 21, 2025 Donidalorsen has the potential to be Ionis' sec
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
11:06am, Thursday, 31'st Oct 2024
Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HAE vs. BSX: Which Stock Is the Better Value Option?
12:42pm, Wednesday, 30'th Oct 2024
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportu
